Trials / Unknown
UnknownNCT03504449
Surgery Without Neoadjuvant Chemoradiotherapy Compared With Neoadjuvant Chemoradiotherapy for Rectal Cancer With Negative Circumferential Resection Margin Based on MRI Assessment, a Perspective Multicenter Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 350 (estimated)
- Sponsor
- Beijing Chao Yang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
For now, neoadjuvant chemoradiotherapy is routinely performed for T3N1-2M0 rectal cancer. However, there are lots of complications following neoadjuvant chemoradiotherapy, such as Wound-related complications, anastomotic leakage, anastomotic stenosis, sexual dysfunction, testicular or ovary failure. Patients undergoing resection for rectal cancer had low rates of local recurrence and long disease-free survival regardless of whether an APR, CAA or low AR was performed. The main purpose of preoperative radiotherapy is to lower the local recurrence. For the T3N1-2M0 rectal cancer with negative circumferential resection margin based on MRI assessment, we suppose might not necessary to receive neoadjuvant chemoradiotherapy, for operation can achieve the negative circumferential resection margin.
Conditions
- Circumferential Resection Margin
- Intraoperative Perforation of Rectum
- Local Recurrence of Malignant Tumor of Rectum
- Disease-free Survival
- Overal Survival
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | neoadjuvant chemoradiotherapy |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2018-04-20
- Last updated
- 2021-02-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03504449. Inclusion in this directory is not an endorsement.